Recognizing Dissociative Disorders in Patients With Chemical Dependency
Abstract
Atypical relapses and unusually intense emotional pain in patients being treated for chemical dependency can alert clinicians to the possibility of comorbid dissociative disorders. The DES can be given as a simple screening instrument. Diagnoses should be based on a follow-up clinical interview and may be supported by administration of the DDIS or SCID-D. Referral for concurrent individual psychotherapy to a clinician knowledgeable about dissociative disorders is recommended.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
